ICU Medical, Inc. (ICUI)

NasdaqGS · Medical Instruments & Supplies

169.85
-0.96 (-0.56%)
Updated Sep 2, 10:02 PM ET
AI Rating
Buy
Overall Score
63
Trend
100
Momentum
31
Risk
48

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Aug 20, 2025 260 sessions Sep 1, 2026

AI Analysis

ICU Medical, Inc. is trading at $169.85, down 0.56% on the session. The 50 day average sits at $165.69 and the 200 day at $145.13, which puts the stock in a uptrend. RSI is at 44.7, which reads as weak, and MACD is bearish crossover. Volume is above average.

The nearest support is around $164.09 with resistance near $176.27, so that band frames the current range. Average daily movement is roughly $5.03, or about 3.0% of the share price, which is what any stop placement has to allow for. The overall health score of 63 out of 100 combines a trend score of 100, momentum of 31 and a risk score of 48.

Technical indicators

RSI (14)
44.7
weak
MACD
2.614
bearish crossover
SMA 20
179.23
SMA 50
165.69
SMA 200
145.13
uptrend
ATR (14)
5.03
avg daily range
Support
164.09
Resistance
176.27
Volume vs 20d
1.14x
above average
Volatility
44.4%
annualised
1 month
-1.23%
3 months
+30.91%

About ICU Medical, Inc.

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.